Skip to content

The effect of multidisciplinary Preventive Antenatal Educational Program on Allergic Disease (PEAPAD) incidences and outcomes in children: a randomized controlled study

The effect of multidisciplinary Preventive Antenatal Educational Program on Allergic Disease (PEAPAD) incidences and outcomes in children: a randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040463
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-11-30
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic diseases

Interventions

Intervention group:Preventive Antenatal Educational Program on Allergic Disease
Control group:Standard care

Sponsors

Beijing Daxing District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Run-in phase inclusion criteria: 1. Enlisted in the birth registry of Daxing Teaching Hospital of Capital Medical University and intend to give birth at this location; 2. Women aged >=18 years; 3. Less than 14+6 gestational week when recruited as measured by last menstrual period; 4. Residents of Daxing and intend to remain residing in Daxing for at least two years postpartum; 5. Written consent form. Randomization phase inclusion criteria: 1. Enlisted in the birth registry of Daxing Teaching Hospital of Capital Medical University and intend to give birth at this location; 2. Less than 14+6 gestational week when recruited as measured by last menstrual period; 3. Residents of Daxing and intend to remain residing in Daxing for at least two years postpartum; Withdrawal criteria: 1. Still birth; 2. Abortion; 3. Rare comorbidities that present after inclusion into the study including but not limited to malignancies, amniotic fluid embolism, eclampsia, and major birth abnormalities of the child.

Exclusion criteria

Exclusion criteria: 1. Planned abortion; 2. Rare comorbidities of the mother that may cause miscarriage and congenital disabilities as determined by OBs, including but not limited to malignancies, congenital heart diseases, monogenetic diseases; 3. Recurrent miscarriage.

Design outcomes

Primary

MeasureTime frame
Whether there is atopic dermatitis;

Secondary

MeasureTime frame
Time to first AD attack;Time of first topical corticosteroids;Infant quality of life evaluation;SCORAD score for severity of disease if AD is onset;AD episodes;Duration of onset of AD (IGA>=2 points) and time to disease-free (IGA<2 points);Is there a baby wheezing;Whether there is allergic rhinitis;Is there food sensitivity;Parents' awareness of allergic diseases, skin care procedures and hormones;Parental knowledge on skin care and atopic dermatitis;Asthma incidence;Cumulative clinical visit duration;

Countries

China

Contacts

Public ContactXiuhua Ma

Beijing Daxing District People's Hospital

mxhdxqyy@126.com+86 13381021859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026